Matched sibling versus matched unrelated allogeneic hematopoietic stem cell transplantation in children with severe acquired aplastic anemia: Experience of the Polish pediatric group for hematopoietic stem cell transplantation

Archivum Immunologiae et Therapiae Experimentalis

Volumn 60, Issue 3, 2012, Pages 225-233

  Szpecht, Dawid ^a   Gorczyńska, Ewa ^b   Kałwak, Krzysztof ^b   Owoc Lempach, Joanna ^b   Choma, Marta ^c   Styczyński, Jan ^d   Goździk, Jolanta ^e   Dłużniewska, Agnieszka ^e   Wysocki, Mariusz ^d   Kowalczyk, Jerzy R ^c   Chybicka, Alicja ^b   Pieczonka, Anna ^a   Wachowiak, Jacek ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c University Children's Hospital   (Poland)

^d NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^e JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Children; Matched sibling donor; Matched unrelated donor; Severe acquired aplastic anemia

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; LYMPHOCYTE ANTIBODY; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; TREOSULFAN;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CD34 SELECTION; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BLOOD LEVEL; ENGRAFTMENT; EVENT FREE SURVIVAL; FEMALE; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; LONG TERM CARE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MATCHED SIBLING DONOR; MATCHED UNRELATED DONOR; MORTALITY; ORGAN DONOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SAFETY; POLAND; PRESCHOOL CHILD; PROBABILITY; SCHOOL CHILD; SEVERE ACQUIRED APLASTIC ANEMIA; SURVIVAL RATE; TREATMENT FAILURE; WHOLE BODY RADIATION;

EID: 84863719907     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-012-0174-1     Document Type: Article

References (29)

1. Bacigalupo A, Oneto R, Bruno B et al (2000) Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Blood and Marrow Transplantation. Acta Haematol 103:19-25 (Pubitemid 30150902)
2. Bacigalupo A, Locatelli F, Lanino E et al (2005) Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplant 36:947-950 (Pubitemid 41741556)
3. Bacigalupo A, Socie' G, Lanino E et al (2010) Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party. Haematologica 95:976-982
4. Bunin N, Aplenc R, Iannone R et al (2005) Unrelated donor bone marrow transplantation for children with severe aplastic anemia: minimal GVHD and durable engraftment with partial T cell depletion. Bone Marrow Transplant 35:369-373 (Pubitemid 40309482)
5. Deeg HJ (1994) Prophylaxis and treatment of acute graft-versus-host disease: current state, implications of new immunopharmacologic compounds, and future strategies to prevent and treat acute GvHD in hight-risk patients. Bone Marrow Transplant 14(suppl 4):S56-S60
6. Deeg HJ, Seidel K, Casper J et al (1999) Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy. Biol Blood Marrow Transplant 5:243-252
7. Deeg HJ, O'Donnell M, Tolar J et al (2006) Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood 108:1485-1491 (Pubitemid 44316112)
8. Führer M (2008) Risk-adapted procedures for HSCT from alternative donor in children with severe aplastic anaemia. Bone Marrow Transplant 42(Suppl 2):S97-S100
9. Führer M, Claviez A, Klein B et al (2009) Re-transplantation from the same unrelated donor in three adolescents with severe aplastic anemia after graft rejection. Klin Padiatr 221:358-361
10. Giebel S, Wojnar J, Krawczyk-Kulis M et al (2006) Treosulfan, cyclophosphamide and antithymocyte globulin for allogeneic hematopoietic cell transplantation in acquired severe plastic anemia. Ann Tranplant 11:23-27
11. Glucksberg H, Storb R, Fefer A et al (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 18:295-303
12. Hsieh MY, Chiou TJ, Hung GY et al (2010) Outcomes of matched sibling and alternative donor stem cell transplantation for 26 children with severe aplastic anemia. Int J Hematol 91:54-60
13. International Agranulocytosis and Aplastic Anemia Study (1987) Incidence of aplastic anemia: the relevance of diagnostic criteria. Blood 70:1718-1721
14. Kennedy-Nasser AA, Leung KS, Mahajan A et al (2006) Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia. Biol Blood Marrow Transplant 12:1277-1284 (Pubitemid 44858261)
15. Kojima S, Matsuyama T, Kato S et al (2002) Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Blood 100:799-803 (Pubitemid 34832604)
16. Kosaka Y, Yagasaki H, Sano K et al (2008) Prospective multicenter trial comparing repeated immunosuppressive therapy with stemcell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia. Blood 111:1054-1059 (Pubitemid 351222518)
17. Kumar R, Prem S, Mahapatra M et al (2006) Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripherial blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia. Bone Marrow Transplant 37:745-749
18. Locasciulli A, Oneto R, Bacigalupo A et al (2007) Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation. Hematologica 92:e122
19. Maury S, Balère-Appert ML, Chir Z et al (2007) Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient. Haematologica 92:589-596 (Pubitemid 350144261)
20. Maury S, Bacigalupo A, Anderlini P et al (2009) Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen. Haematologica 94:1312-1315
21. Passweg JR, Pérez WS, Eapen M et al (2006) Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. Bone Marrow Transplant 37:641-649
22. Perez-Albuerne ED, Eapen M, Klein J et al (2008) Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia. Br J Haematol 141:216-223 (Pubitemid 351406211)
23. Schrezenmeier H, Passweg JR, Marsh JC et al (2007) Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood 110:1397-1400 (Pubitemid 47281442)
24. Shulman HM, Sullivan KM, Weiden PL et al (1980) Chronic graftversus- host syndrome in man. A long term clinicopathologic study of 20 Seatle patients. Am J Med 69:204-217 (Pubitemid 10036817)
25. Srinivasan R, Takahashi Y, McCoy JP et al (2006) Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation. Br J Haematol 133:305-314
26. Storb R, Blume KG, O'Donnell MR et al (2001) Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers. Biol Blood Marrow Transplant 7:39-44 (Pubitemid 32229501)
27. Viollier R, Socié G, Tichelli A et al (2008) Recent improvement in outcome of unrelated donor transplantation for aplastic anemia. Bone Marrow Transplant 41:45-50
28. Yagasaki H, Takahashi Y, Hama A et al (2010) Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia. Bone Marrow Transplant 45:1508-1513
29. Young NS, Calado RT, Scheinberg P (2006) Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108:2509-2519